This work on osteoporosis describes its epidemiology and goes on to discuss bone mass measurement, biochemical bone markers and the use of oestrogens and progestogens in osteoporosis to prevent bone loss. The cardiovascular effects of the use of these hormones is assessed.
This work on osteoporosis describes its epidemiology and goes on to discuss bone mass measurement, biochemical bone markers and the use of oestrogens and progestogens in osteoporosis to prevent bone loss. The cardiovascular effects of the use of these hormones is assessed.
Sprache
Verlagsort
Verlagsgruppe
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Illustrationen
Maße
Höhe: 226 mm
Breite: 152 mm
Gewicht
ISBN-13
978-0-7020-1548-9 (9780702015489)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
Epidemiology of osteoporosis; bone mass measurement (advantages and disadvantages); what do we know about biochemical bone markers?; biochemical markers (a new approach for diagnostic procedures in the future osteoporosis patient); the risk of osteoporosis in ageing women today and tomorrow; osteoporosis prevention with oestrogens and progestogens; why do oestrogens prevent bone loss?; oestrogens/progestogens in the treatment of established osteoporosis; do we have any alternative to sex steroids in the prevention and treatment of osteoporosis?; effects of sex steroids on serum lipids and lipoproteins; do oestrogens protect against cardiovascualr risks?; are progestogens dangerous or safe from a cardiovascular point of view?; risk benefit ratio of hormonal therapy in the menopause; cost effectiveness of hormonal replacement therapy.
